Records containing: Plasma Cell Disorder

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

All FDA submission records EMA medicine records ClinicalTrials.gov record updates ClinicalTrials.gov records with results posted

CLINICAL_TRIALS study record update · 2026-04-16
Pre-malignant States to Hematologic Malignancies in Firefighters
CLINICAL_TRIALS study record update · 2025-10-29
A Phase I/II Study of Subcutaneous Daratumumab Administration in the Anterior Upper Thigh Vs Abdomen in Patients With Plasma Cell Disorders
CLINICAL_TRIALS study record update · 2025-06-15
High Dose Ascorbic Acid (HDAA) in Patients With Plasma Cell Disorders
CLINICAL_TRIALS study record update · 2024-07-24
A Phase 1/2a, First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of HDP-101 in Patients With Plasma Cell Disorders Including Multiple Myeloma
CLINICAL_TRIALS study record update · 2024-07-23
Haploidentical Allogeneic Peripheral Blood Transplantation: Clinical Trial and Laboratory Correlates Examining Checkpoint Immune Regulators' Expression
Organize your saved records without ads with Plus.
CLINICAL_TRIALS study record update · 2024-03-26
Disease Characteristics and Treatment Response in Plasma Cell Disorders Patients Based on Genetic Abnormalities From Fluorescence In Situ Hybridization and Next Generation Sequencing
CLINICAL_TRIALS study record update · 2023-10-30
Evaluation of the Plasma Cell Disorders Panel (BD OneFlow™ PCST and BD OneFlow™ PCD) on the BD FACSLyric™ Flow Cytometer Using Leftover, De-identified Specimens
CLINICAL_TRIALS study record update · 2019-04-19
Novel Support Options in Autologous Stem Cell Transplant for Multiple Myeloma
CLINICAL_TRIALS study record update · 2016-05-17
Investigation of the Enhancement of the Response to Hepatitis B Vaccine by Lenalidomide (RevlimidTM, CC-5013) in Plasma Cell Dyscrasias